首页> 外国专利> METHOD FOR PREDICTING SUPER-LIGHT ON A CARDIAC RESYNCHRONISING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE

METHOD FOR PREDICTING SUPER-LIGHT ON A CARDIAC RESYNCHRONISING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE

机译:慢性心力衰竭患者心脏重新同步治疗的超光预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to clinical cardiology. Echocardiographic examination is performed to determine duration of aortal pre-expelling period (ZAO) and presence of septal flush (SF), then function (F) value is calculated by original formula. That is followed by determining the probability of developing a superstorm in a cardiac resynchronizing therapy (P) according to the original formula. If the P value is less than 0.576, the patient is considered to belong to a group of non-super-responders, if the P value is more than or equal to 0.576 – to the group of super-responders, and a superstem is predicted for cardiac resynchronization therapy.;EFFECT: method provides higher clinical effectiveness in the patients with severe chronic cardiac failure ensured by higher accuracy of prediction of the development of the super-torsion on the patient's CT in the patients, which improves their selection for implantation of the cardiac resynchronizing therapy devices.;1 cl, 1 ex
机译:田地:医学。物质:发明是指药物,即临床心脏病学。进行超声心动图检查以确定主动脉预排出时期(ZAO)的持续时间和隔膜冲洗(SF)的存在,然后通过原始公式计算功能(F)值。接下来,根据原始公式确定在心脏重新同步治疗(P)中开发巨星的概率。如果P值小于0.576,则患者被认为属于一组非超级响应者,如果P值大于或等于0.576 - 到一组超响应者,并且预测了超级资金用于心脏重新同步疗法。;效果:方法在患者CT在患者CT的超扭转发展的更高准确性,可确保患者患者提供更高的临床效果,从而提高了他们的植入选择心脏重新同步治疗装置。; 1 cl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号